Efficacy of IVIG (intravenous immunoglobulin) for corona virus disease 2019 (COVID-19): A meta-analysis

BACKGROUND: The benefit of IVIG (Intravenous Immunoglobulin) therapy for COVID-19 remains controversial. We performed a meta-analysis to investigate the efficacy of IVIG treatment in patients with COVID-19. METHODS: We searched articles from Web of Science, PubMed, Embase, the Cochrane Library, MedR...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Huai-rong, Cheng, Xuan, Li, Yun, Luo, Wen-wen, Zhang, Qi-zhi, Peng, Wen-xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084608/
https://www.ncbi.nlm.nih.gov/pubmed/34162133
http://dx.doi.org/10.1016/j.intimp.2021.107732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084608/
https://www.ncbi.nlm.nih.gov/pubmed/34162133
http://dx.doi.org/10.1016/j.intimp.2021.107732

Ejemplares similares